Literature DB >> 3803911

Etiological heterogeneity in Hodgkin's disease: HLA linked and unlinked determinants of susceptibility independent of histological concordance.

A Chakravarti, S L Halloran, S J Bale, M A Tucker.   

Abstract

Forty-one multiplex families, from published sources and new data from the National Cancer Institute, segregating for Hodgkin's disease and HLA, have been studied. A reanalysis of these data strongly suggests a recessive mode of inheritance for susceptibility to Hodgkin's disease. The HLA haplotype sharing data between affected relatives demonstrate that approximately 60% of cases in multiplex families are due to an HLA-linked susceptibility gene, the remaining 40% being due to other familial factors. The data clearly support the hypothesis of etiological heterogeneity for Hodgkin's disease, with both HLA-linked and HLA-unlinked factors being responsible. Finally, there is an increased concordance of histological types between affected relatives, but this concordance seems independent of HLA sharing.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3803911     DOI: 10.1002/gepi.1370030605

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  4 in total

1.  Pseudoautosomal linkage of Hodgkin disease.

Authors:  A S Whittemore; M C Shih
Journal:  Am J Hum Genet       Date:  2000-08       Impact factor: 11.025

2.  Pseudoautosomal linkage of Hodgkin disease.

Authors:  M Horwitz; P H Wiernik
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

Review 3.  The genetics of familial lymphomas.

Authors:  Rina Siddiqui; Kenan Onel; Flavia Facio; Kenneth Offit
Journal:  Curr Oncol Rep       Date:  2004-09       Impact factor: 5.075

4.  The association of HLA-class I and class II with Hodgkin's lymphoma in Iranian patients.

Authors:  Arezou Sayad; Mohammad Taghi Akbari; Mahshid Mehdizadeh; Abolfazl Movafagh; Abbas Hajifathali
Journal:  Biomed Res Int       Date:  2014-05-21       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.